Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear reprogramming with a non-integrating human RNA virus.

Christopher B Driscoll1, Jason M Tonne2, Moustafa El Khatib3

  • 1Department of Molecular Medicine, and Virology and Gene Therapy Graduate Track, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905, USA. driscoll.christopher@mayo.edu.

Stem Cell Research & Therapy
|April 19, 2015
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trial.

PloS one·2026
Same author

Myd88 Deficiency Accelerates Retinal Degeneration and Alters Microglial Dynamics in a Mouse Model of Retinitis Pigmentosa.

Investigative ophthalmology & visual science·2026
Same author

Extracellular release of cytotoxic aggregates from HSV-1-replicating SH-SY5Y cells: involvement of alpha-synuclein and poly-ubiquitin conjugates.

Experimental cell research·2026
Same author

Initial Site of Macular Involvement in Central Retinal Dystrophies Revealed by Fundus Autofluorescence and Optical Coherence Tomography.

Investigative ophthalmology & visual science·2026
Same author

Efficient and reliable measles reprogramming platform for the generation of human iPSC.

Molecular therapy. Advances·2026
Same author

Genotype-Phenotype Correlations in RPGRIP1-Associated Retinal Dystrophy in a Nationwide Japanese Cohort.

American journal of ophthalmology·2026
This summary is machine-generated.

Measles virus (MV) vectors efficiently reprogram human cells into induced pluripotent stem cells (iPSCs). This non-integrating gene transfer platform shows promise for clinical applications in regenerative medicine.

Area of Science:

  • Stem cell biology
  • Virology
  • Gene therapy

Background:

  • Induced pluripotent stem cells (iPSCs) are crucial for regenerative medicine.
  • Traditional iPSC generation uses integrating vectors, posing potential risks.
  • Novel non-integrating methods are needed for safer iPSC production.

Purpose of the Study:

  • To investigate the feasibility of using measles virus (MV)-based vectors for iPSC generation.
  • To develop a non-integrating gene transfer system for nuclear reprogramming.

Main Methods:

  • Engineered a one-cycle MV vector expressing OCT4 and combined it with lentiviral vectors for SOX2, KLF4, and cMYC.
  • Transduced human skin fibroblasts with the MV vector cocktail.
  • Assessed iPSC colony formation and pluripotency marker expression.

Related Experiment Videos

Main Results:

  • Efficient transduction of human fibroblasts and formation of iPSC colonies.
  • Confirmed induction of pluripotency markers (SSEA-4, TRA-1-60, Nanog) via RT-PCR and immunostaining.
  • Demonstrated pluripotency through teratoma formation and differentiation into cardiomyocytes.

Conclusions:

  • Measles virus vectors can efficiently induce nuclear reprogramming.
  • The MV vector system offers an RNA-based, non-integrating platform for reprogramming.
  • This approach has potential for immediate clinical translation due to MV's safety record.